0 CHECKOUT

Netherlands Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3499779
  • November 2015
  • Region: Netherlands, Holland
  • 99 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • DSM
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Pharming Group
  • MORE

The Netherlands has a well-developed healthcare system due to generous public expenditure over the years. Despite newly introduced cost-cutting measures, government spending on healthcare will continue to increase in local currency terms, especially as the wider eurozone recovers. However, the country's aging population will put pressure on government finances over the longer-term, inevitably leading to further price caps on medicines.

Headline Expenditure Projections
- Pharmaceuticals: EUR5.92bn (USD7.93bn) in 2014 to EUR5.80bn (USD6.38bn) in 2015; -2.0% in local currency terms and -19.6% in US dollar terms. Forecast in line with last quarter.

- Healthcare: EUR73.28bn (USD98.19bn) in 2014 to EUR74.29bn (USD81.72bn) in 2015; +1.4% in local currency terms and -16.8% in US dollar terms. Forecast in line with last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • DSM
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Pharming Group
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Netherlands 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2013-2019)

Industry Risk Reward Index

Western Europe Risk/Reward Index

Netherlands Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Developments

Intellectual Property Regime

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Netherlands 2009-2014)
Table: Healthcare Personnel (Netherlands 2009-2014)
Table: Healthcare Activity (Netherlands 2009-2014)
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006
Table: Biosimilars Approved In The EU

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Pharmaceutical Production, 1995-2010 (EUR '000s)
Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

DSM

GlaxoSmithKline

Merck & Co

Novartis

Pfizer

Pharming Group

Qiagen

Sanofi

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Netherlands 1990-2025)
Table: Key Population Ratios (Netherlands 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Netherlands 1990-2025)
Table: Population By Age Group (Netherlands 1990-2025)
Table: Population By Age Group % (Netherlands 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

DSM
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Pharming Group
Qiagen
Sanofi

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S